Becton Dickinson said on Tuesday that it has submitted a premarket approval (PMA) supplement to the US Food and Drug Administration for an expanded version of its Onclarity human papilloma virus (HPV) assay.... Read More >

Beckman Coulter Life Sciences and IncellDx said today that they have partnered to promote in Europe four newly developed cancer assays that incorporate technology from each company.... Read More >

Becton Dickinson is advising its shareholders to reject an unsolicited mini-tender offer they may have received to sell their shares of the company's stock.... Read More >

Australian molecular diagnostics firm Genetic Signatures has raised $25 million, it said recently. Read More >

A consortium led by private equity firms Cinven and Astorg said recently that it has signed an agreement to acquire life science tools company LGC for an undisclosed amount, subject to regulatory approval and other customary clearances.... Read More >

British life science reagents and tools company Abcam said recently that it has signed an agreement to use BrickBio's proprietary bioconjugation platform to develop research and diagnostic products.... Read More >

Invitae said recently that it will acquire Clear Genetics, a developer of software that supports the delivery of genetics services at scale, for approximately $50 million. ... Read More >

Expedeon announced recently that it has agreed to sell its immunology and proteomics businesses to UK-based life science reagents and tools company Abcam for €120 million ($130.0 million) in cash.... Read More >

Castle Biosciences reported after the close of the market recently that its third quarter revenues skyrocketed 300 percent year over year due to growth in the firm's DecisionDx- Melanoma test report volume.... Read More >

Liquid biopsy firm Lexent Bio recently announced a non-exclusive partnership with Illumina to develop an in vitro diagnostic kit for cancer. Read More >